本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Psyence Biomedical Ltd

4.63
-0.6900-12.97%
盘后4.54-0.0900-1.94%19:57 EDT
成交量:11.98万
成交额:59.15万
市值:270.05万
市盈率:-0.01
高:5.34
开:5.23
低:4.45
收:5.32
数据加载中...
2025/03/13

SEC问询函

Form CORRESP - Correspondence
2025/01/28

SEC问询函

Form CORRESP - Correspondence
2025/01/24

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/12/30

SEC问询函

Form CORRESP - Correspondence
2024/12/20

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/12/13

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/09

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/12/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

SEC问询函

Form CORRESP - Correspondence
2024/10/30

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/10/08

SEC问询函

Form CORRESP - Correspondence
2024/10/02

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/08/27

SEC问询函

Form CORRESP - Correspondence
2024/08/20

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/07/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/27

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/13

SEC问询函

Form CORRESP - Correspondence